, , , 2014, 2014, , , , , , , , , , 2



Our vision is to drastically reduce mortality caused by infectious diseases through increased use of affordable diagnostics.

Company history

Immuno-Mycologics, Inc. (IMMY) is a US-based organization that was founded in 1979 with a particular focus in mycology, or the study of fungi.  Back then, mycology was virtually a forgotten area in the clinical laboratory, and there was a definite need for diagnostic products to detect fungal infections.

Over the last thirty years, IMMY has evolved from a company that filled a need in the market to an organization whose main focus is to save lives—period.  We still devote a large amount of time to manufacturing high-quality fungal diagnostics, but our scope has broadened immensely.

Our most recent endeavors have centered on improving diagnostics for the developing world.  Areas like sub-Saharan Africa lack the necessary infrastructure to provide patients with adequate healthcare.

However, we can help alleviate this problem by delivering diagnostics that can be performed without high-technology laboratory equipment or even electricity in general.

Saving Lives

IMMY takes pride in producing reliable, accurate diagnostics, but above all we want to play a role in raising the standard of healthcare for patients all over the world.

FCOI Policy